China Universal Asset Management Co., Ltd. - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 70 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q1 2024$500,653
+290.7%
12,630
+87.9%
0.06%
+156.0%
Q4 2023$128,140
+781.9%
6,723
+429.8%
0.02%
+525.0%
Q3 2023$14,530
+124.7%
1,269
+101.7%
0.00%
+100.0%
Q2 2023$6,466
+34.4%
629
+1.0%
0.00%0.0%
Q1 2023$4,810
+40.2%
623
+33.4%
0.00%
+100.0%
Q4 2022$3,432
+71.6%
467
+63.9%
0.00%0.0%
Q3 2022$2,0002850.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,199,011$24,629,0003.99%
BVF INC/IL 675,759$7,569,0000.91%
Orbimed Advisors 3,298,516$36,943,0000.47%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 913,100$10,227,0000.40%
TIGER MANAGEMENT L.L.C. 162,728$1,823,0000.28%
Rock Springs Capital Management LP 150,000$1,680,0000.08%
Sowell Financial Services LLC 15,714$168,0000.04%
Spark Investment Management LLC 16,600$185,0000.01%
ALPINE WOODS CAPITAL INVESTORS, LLC 10,000$112,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 38,750$434,0000.01%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders